Bortezomib and high dose melphalan as conditioning regimen b
Publicado: Jue Nov 12, 2009 6:52 pm
Bortezomib and high dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase II study of the Intergroupe Francophone du Myelome (IFM).
Smart Brief IMF
http://www.ncbi.nlm.nih.gov/pubmed/1988 ... dinalpos=7
Saludos
Smart Brief IMF
http://www.ncbi.nlm.nih.gov/pubmed/1988 ... dinalpos=7
Saludos